GlassScriptPhysician profile
Pallavy Reddy
NPI 1740277664
$24,287.91
in general payments reported to CMS, 2019-2025
50 companies · $989 in 2025
The $989 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $6,574 · 2021: $539 · 2022: $890 · 2023: $566 · 2024: $923 · 2025: $989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,478.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $14,746.20 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $1,645.92 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Dexcom, INC. | $811.32 | 2019-2025 | Dexcom G6 Transmitter |
| Mannkind Corporation | $735.19 | 2019-2023 | Afrezza |
| Lilly USA, LLC | $495.26 | 2019-2025 | Mounjaro, Zepbound |
| Corcept Therapeutics | $439.52 | 2019-2025 | Korlym |
| Amgen INC. | $430.38 | 2019-2025 | Evenity, Prolia, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $406.89 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $356.03 | 2019-2024 | |
| Insulet Corporation | $340.36 | 2019-2024 | Omnipod |
| Amneal Pharmaceuticals LLC | $314.74 | 2019-2024 | Unithroid |
| Janssen Pharmaceuticals, INC | $289.92 | 2019-2020 | |
| Abbott Laboratories | $265.77 | 2019-2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $257.39 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $248.13 | 2019-2021 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $232.85 | 2019-2023 | |
| Radius Health, INC. | $212.91 | 2019-2025 | Tymlos |
| Regeneron Healthcare Solutions, INC. | $208.11 | 2019 | |
| Merck Sharp & Dohme LLC | $206.64 | 2019 | |
| Xeris Pharmaceuticals, INC. | $141.41 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Pfizer INC. | $126.53 | 2019-2024 | |
| Cequr Corporation | $113.13 | 2024-2025 | Cequr Simplicity |
| Aegerion Pharmaceuticals, INC. | $109.99 | 2019 | |
| Medtronic, INC. | $104.47 | 2024-2025 | Minimed 780g, Inceptiv |
| Ibsa Pharma INC. | $102.84 | 2019-2024 | Licart, Tirosint, Tirosint |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.48 | 2019-2022 | |
| Beta Bionics, INC. | $89.23 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Novartis Pharmaceuticals Corporation | $87.92 | 2024-2025 | |
| Lifescan, INC. | $85.95 | 2019-2020 | |
| Shire North American Group INC | $73.37 | 2019 | |
| Endo Pharmaceuticals INC. | $63.37 | 2019-2020 | |
| Valeritas, INC. | $53.18 | 2019 | |
| Alexion Pharmaceuticals, INC. | $43.73 | 2019-2025 | Strensiq |
| Bayer Healthcare Pharmaceuticals INC. | $37.48 | 2022-2025 | |
| Antares Pharma, INC. | $35.68 | 2019-2024 | Xyosted |
| Horizon Therapeutics Plc | $29.47 | 2019-2023 | Tepezza |
| Sequel Med Tech, LLC | $27.09 | 2025 | Twiist |
| Allergan, INC. | $24.02 | 2019-2020 | |
| Amphastar Pharmaceuticals, INC. | $21.52 | 2024 | |
| Tolmar, INC. | $21.42 | 2025 | Jatenzo |
| Companion Medical, INC. | $20.89 | 2020 | |
| Ascensia Diabetes Care US INC. | $19.94 | 2025 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Esperion Therapeutics, INC. | $17.58 | 2024 | Nexletol |
| Halozyme INC | $16.78 | 2023 | |
| Rgh Enterprises LLC | $15.56 | 2025 | |
| Chiesi USA, INC. | $15.34 | 2024 | Mycapssa |
| Averitas Pharma INC. | $14.12 | 2024 | Qutenza |
| Kowa Pharmaceuticals America, INC. | $11.94 | 2019 | |
| Clarus Therapeutics INC. | $2.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pallavy Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.